Effect of Giving Reduced Fluid in Children After Trauma

Not Applicable

Recruiting

• Conditions: Wounds and Injuries; Critical Illness; Pediatrics; Fluid Therapy; General Surgery

• Registration Number: NCT04201704
• Lead Sponsor: Columbia University

Brief Summary

This study is designed to help decide how much intravenous (IV) fluid should be given to pediatric trauma patients. No standard currently exists for managing fluids in critically ill pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma patients got high volumes of IV fluid. Recent studies in adults show that patients actually do better by giving less fluid. The investigators do not know if this is true in children and this study is designed to answer that question and provide guidelines for IV fluid management in children after trauma.

Detailed Description

Aggressive fluid resuscitation has been the cornerstone of early post-operative and trauma management for decades. However, recent prospective adult studies have challenged this practice, linking high volume crystalloid resuscitation to increased mortality, cardiopulmonary, gastrointestinal and hematologic complications. A retrospective study the investigators recently performed at their quaternary-care children's hospital echoed these results. High quality prospective data is necessary to determine best practice guidelines in our pediatric surgery and trauma patients.

Currently, no standard exists to guide management of crystalloid fluid administration in trauma patients. Both liberal and restricted strategies are in use, dependent on physician discretion. The investigators propose the first randomized controlled trial (RCT) comparing a liberal to a restricted fluid management strategy in critically ill pediatric trauma patients. The objective of this comparative effectiveness study is to conduct a multicenter (around 10 sites) randomized controlled trial (RCT) to determine whether liberal or restricted fluid administration leads to better outcomes in these patients.

Study Timeline

• Study Start: 2018-08-27
• Study First Submitted: 2019-12-12
• Study First Submitted QC: 2019-12-14
• Study First Posted: 2019-12-17
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-02
• Last Update Posted: 2025-05-04
• Primary Completion: 2026-08
• Study Completion: 2026-09

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Trauma patients older than 6 months and younger than 15 years admitted to the pediatric intensive care unit (PICU)
• Patients admitted to the PICU directly from the Emergency Department (ED)
• Patients admitted to the PICU from the operating room (OR)
• Patients transferred to PICU from outside facility ED (need to have been in ED 12 hours or less)

Exclusion Criteria

• Patients transferred to PICU from outside PICU or inpatient floor
• Patients transferred to PICU from outside facility ED if >12 hours
• Patients expected to be discharged from the PICU within 24 hours
• Patient with congenital heart disease as defined by a congenital cardiac defect requiring surgery or medication
• Patient with diagnosis of chronic cardiac condition (e.g. hypertension, cardiac arrhythmia)
• Patients with chronic kidney disease as defined by an abnormality of kidney structure or function, present for more than 3 months, with implications to health
• Post-operative transplant, cardiac, and neurosurgical patients
• Patients with traumatic brain injury
• Patients with any disease that may affect baseline blood pressure and heart rate (endocrine disorders, certain genetic disorders, mitochondrial diseases)
• Hypotension requiring vasopressor therapy
• If massive transfusion protocol initiated

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Overall complications	Up to time of discharge (up to approximately 1 month)	Total number of complications defined as pulmonary edema, hemorrhage, deep cavity infection, anastomotic dehiscence, thrombosis, death, superficial wound infection, ileus, and pneumonia.

Secondary Outcome Measures

Name	Time	Method
Number of Hours of ICU Length of Stay	Up to time of discharge (up to approximately 1 month)	length of time in pediatric intensive care unit in hours
Number of Hours of Hospital Length of Stay	Up to time of discharge (up to approximately 1 month)	length of time in hospital to inpatient discharge in hours
Number of hours on Supplemental Oxygen	Up to time of discharge (up to approximately 1 month)	length of time patient requires non-invasive supplemental O2 in hours
Number of Hours on Ventilator	Up to time of discharge (up to approximately 1 month)	length of time patient requires invasive ventilation in hours

Trial Locations

Locations (4)

John R. Oishei Children's Hospital of Buffalo; 🇺🇸 Buffalo, New York, United States

Columbia University Irving Medical Center NewYork-Presbyterian Morgan Stanley Children's Hospital; 🇺🇸 New York, New York, United States

University of Rochester, Golisano Children's Hospital; 🇺🇸 Rochester, New York, United States

Le Bonheur Children's Hospital; 🇺🇸 Memphis, Tennessee, United States